Acurx Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Acurx Pharmaceuticals (ACXP).

Price Target Range — 9 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$144Upside to Avg. PT+12960.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 29, 2026	HC Wainwright & Co.	Matthew Keller	Maintained	Buy	$31
Sep 30, 2025	HC Wainwright & Co.	Matthew Keller	Maintained	Buy	$31
Aug 12, 2025	HC Wainwright & Co.	Matthew Keller	PT Raise	Buy	$8→$31
May 15, 2025	HC Wainwright & Co.	Matthew Kelsey	Assumes	Buy	$160
Mar 19, 2025	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$240
Jan 13, 2025	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$240
Jan 10, 2025	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$240
Dec 10, 2024	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$240
Nov 14, 2024	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$240
Aug 12, 2024	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$240
May 16, 2024	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$240
Mar 19, 2024	HC Wainwright & Co.	Ed Arce	PT Cut	Buy	$280→$240
Feb 28, 2024	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$280
Dec 15, 2023	HC Wainwright & Co.	Ed Arce	PT Raise	Buy	$260→$280
Nov 15, 2023	HC Wainwright & Co.	Ed Arce	Maintained	Buy	$260

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target

HC Wainwright & Co. analyst Matthew Keller reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $31 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target

HC Wainwright & Co. analyst Matthew Keller reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $31 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $31

HC Wainwright & Co. analyst Matthew Keller maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and raises the price target from $8 to $31.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Assumes Acurx Pharmaceuticals at Buy, Announces Price Target of $8

HC Wainwright & Co. analyst Matthew Kelsey assumes Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy rating and announces Price Target of $8.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $12 price target.

Benzinga Newsdesk

Acurx Pharmaceuticals Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Acurx Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $31

PRO
HC Wainwright & Co. Assumes Acurx Pharmaceuticals at Buy, Announces Price Target of $8

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

People Also Watch

People Also Watch

Acurx Pharmaceuticals Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Acurx Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target

PROHC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target

PROHC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $31

PROHC Wainwright & Co. Assumes Acurx Pharmaceuticals at Buy, Announces Price Target of $8

PROHC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

PROHC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $31

PRO
HC Wainwright & Co. Assumes Acurx Pharmaceuticals at Buy, Announces Price Target of $8

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target